Nobel Biocare: Trading Statement, Third Quarter 2008

ZURICH, Switzerland, Oct. 9, 2008 (GLOBE NEWSWIRE) -- Nobel Biocare (Nasdaq:NOBN) (Stockholm:NOBE) announced today that the deteriorating economic environment has adversely affected its sales towards the end of September. Nobel Biocare therefore reports 2008 revenues of EUR 133 million for the third quarter, representing a decrease of 2.8% at constant exchange rates (CER) for the quarter. For the first nine months of 2008, revenues were at EUR 457 million, a 1% (CER) decrease compared to prior year.